Prudential Financial Inc. Makes New Investment in Aveanna Healthcare Holdings Inc. $AVAH

Prudential Financial Inc. purchased a new stake in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 105,945 shares of the company’s stock, valued at approximately $554,000. Prudential Financial Inc. owned 0.05% of Aveanna Healthcare at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Banque Transatlantique SA purchased a new position in Aveanna Healthcare in the first quarter worth about $25,000. Jump Financial LLC purchased a new position in shares of Aveanna Healthcare in the first quarter worth approximately $59,000. Diversified Trust Co bought a new stake in Aveanna Healthcare during the second quarter valued at approximately $57,000. MQS Management LLC purchased a new stake in Aveanna Healthcare during the second quarter valued at approximately $59,000. Finally, Belvedere Trading LLC purchased a new stake in Aveanna Healthcare during the second quarter valued at approximately $62,000. Institutional investors own 87.96% of the company’s stock.

Analyst Ratings Changes

AVAH has been the subject of a number of analyst reports. Barclays upgraded Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and increased their price target for the stock from $5.50 to $9.50 in a research note on Tuesday, August 19th. Zacks Research cut Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 20th. BMO Capital Markets started coverage on Aveanna Healthcare in a report on Thursday, November 13th. They issued an “outperform” rating and a $11.00 price target on the stock. Jefferies Financial Group upped their price target on Aveanna Healthcare from $11.00 to $12.50 and gave the stock a “buy” rating in a research note on Tuesday, October 28th. Finally, Royal Bank Of Canada lifted their price objective on shares of Aveanna Healthcare from $8.00 to $10.00 and gave the company a “sector perform” rating in a research report on Friday, October 24th. Five analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Aveanna Healthcare currently has a consensus rating of “Hold” and an average price target of $10.69.

Aveanna Healthcare Trading Down 0.8%

Shares of AVAH opened at $9.13 on Wednesday. The firm has a market capitalization of $1.91 billion, a price-to-earnings ratio of 25.36 and a beta of 2.04. The company has a debt-to-equity ratio of 140.39, a current ratio of 1.23 and a quick ratio of 1.23. Aveanna Healthcare Holdings Inc. has a 1-year low of $3.67 and a 1-year high of $10.32. The company has a 50-day moving average of $9.11 and a 200 day moving average of $7.09.

Aveanna Healthcare (NASDAQ:AVAH) last released its quarterly earnings data on Monday, May 22nd. The company reported $0.04 earnings per share for the quarter. Aveanna Healthcare had a net margin of 3.29% and a negative return on equity of 143.55%. The company had revenue of $450.53 million during the quarter. On average, research analysts expect that Aveanna Healthcare Holdings Inc. will post -0.06 EPS for the current year.

Insider Buying and Selling

In related news, major shareholder J.H. Whitney Equity Partners V sold 1,251,909 shares of the firm’s stock in a transaction on Friday, October 24th. The shares were sold at an average price of $9.00, for a total transaction of $11,267,181.00. Following the completion of the transaction, the insider owned 19,292,787 shares of the company’s stock, valued at $173,635,083. This trade represents a 6.09% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, major shareholder Paul R. Vigano sold 1,500,000 shares of Aveanna Healthcare stock in a transaction dated Friday, October 24th. The shares were sold at an average price of $9.00, for a total value of $13,500,000.00. Following the transaction, the insider owned 362,746 shares of the company’s stock, valued at $3,264,714. The trade was a 80.53% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 32,597,968 shares of company stock worth $293,381,712 in the last three months. Corporate insiders own 7.00% of the company’s stock.

Aveanna Healthcare Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.